Mahdavian E, Spencer H T, Dunlap R B
Department of Chemistry and Biochemistry, University of South Carolina, 730 South Main Street, Columbia, South Carolina, 29208, USA.
Arch Biochem Biophys. 1999 Aug 15;368(2):257-64. doi: 10.1006/abbi.1999.1319.
A naturally occurring mutant of human thymidylate synthase (hTS) that contains a Tyr to His mutation at residue 33 was found to confer 4-fold resistance to 5-fluoro-2'-deoxyuridine (FdUrd), a prodrug of 5-fluoro-2'-deoxyuridine 5'-monophosphate (FdUMP). The crystal structure of hTS implicated this Tyr residue in a drug resistance mechanistic role that may include both substrate binding and catalysis (Schiffer et al., Biochemistry, 34, 16279-16287, 1995). Because of the existence of a defined kinetic scheme and the development of a bacterial expression vector for the overproduction of Escherichia coli TS (ecTS), we chose to initially study the corresponding residue in the bacterial enzyme, Tyr 4 of ecTS. Nine mutant ecTS enzymes that differed in sequence at position 4 were generated. Mutants with a charged or polar side chain (Ser, Cys, Asp, and Arg) and Gly precipitated in the cell paste, resulting in no catalytic activity in cell-free extracts. Although most of the His 4 mutant precipitated, sufficient amounts remained in the cell-free extract to permit isolation to near homogeneity. Wild-type ecTS and mutants with a hydrophobic side chain (Phe, Ile, and Val) were expressed at nearly 30% of the total cellular protein. The k(cat) values for the isolatable mutants were 2- to 10-fold lower than that of the wild-type enzyme, while the K(m) values for 2'-deoxyuridylate (dUMP) and 5,10-methylenetetrahydrofolate (CH(2)H(4)folate) were similar for all the mutants. Dissociation constants for binary complex formation determined by stopped-flow spectroscopy were similar for the wild-type and mutant enzymes for both dUMP and 2'-deoxythymidylate, indicating that this mutation does not significantly alter the binding of the natural nucleotide ligands. However, each mutant enzyme had three- to 5-fold lower affinity for FdUMP in the binary complex compared with the wild-type enzyme, and only His 4 showed a lower affinity for FdUMP in the ternary complex. Analysis of k(burst) showed that the initial binding of CH(2)H(4)folate is weaker for each mutant compared to the wild-type enzyme and that lower k(cat) values were due to compromised rates that govern the chemical transformation of bound substrates to bound products.
人们发现,人胸苷酸合成酶(hTS)的一种天然存在的突变体在第33位残基处发生了酪氨酸到组氨酸的突变,该突变体对5-氟-2'-脱氧尿苷(FdUrd)具有4倍的抗性,FdUrd是5-氟-2'-脱氧尿苷5'-单磷酸(FdUMP)的前体药物。hTS的晶体结构表明该酪氨酸残基在耐药机制中发挥作用,这可能包括底物结合和催化作用(Schiffer等人,《生物化学》,第34卷,16279 - 16287页,1995年)。由于存在明确的动力学机制,并且开发了用于过量表达大肠杆菌TS(ecTS)的细菌表达载体,我们选择首先研究细菌酶中的相应残基,即ecTS的酪氨酸4。生成了9种在第4位序列不同的ecTS突变酶。带有带电或极性侧链(丝氨酸、半胱氨酸、天冬氨酸和精氨酸)以及甘氨酸的突变体在细胞糊中沉淀,导致无细胞提取物中没有催化活性。尽管大多数组氨酸4突变体沉淀了,但仍有足够量的突变体留在无细胞提取物中,以便分离至接近均一状态。野生型ecTS和带有疏水侧链(苯丙氨酸、异亮氨酸和缬氨酸)的突变体表达量接近总细胞蛋白的30%。可分离突变体的k(cat)值比野生型酶低2至10倍,而所有突变体对2'-脱氧尿苷酸(dUMP)和5,10-亚甲基四氢叶酸(CH(2)H(4)叶酸)的K(m)值相似。通过停流光谱法测定的二元复合物形成的解离常数,野生型和突变体酶对dUMP和2'-脱氧胸苷酸的解离常数相似,这表明该突变不会显著改变天然核苷酸配体的结合。然而,与野生型酶相比,每个突变体酶在二元复合物中对FdUMP的亲和力低3至5倍,并且只有组氨酸4在三元复合物中对FdUMP的亲和力较低。对k(burst)的分析表明,与野生型酶相比,每个突变体中CH(2)H(4)叶酸的初始结合较弱,并且较低的k(cat)值是由于控制结合底物向结合产物化学转化的速率受损所致。